|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.43 USD | -1.52% |
|
+3.71% | +19.40% |
| Market Cap | 2.55B 2.22B 2.06B 1.93B 3.61B 240B 3.63B 24.37B 9.45B 118B 9.55B 9.35B 411B | P/E 2026 * |
-7.47x | P/E 2027 * | -7.42x |
|---|---|---|---|---|---|
| Enterprise Value | 1.96B 1.71B 1.58B 1.49B 2.78B 185B 2.8B 18.78B 7.28B 91.05B 7.36B 7.2B 317B | EV / Sales 2026 * |
744x | EV / Sales 2027 * | 170x |
| Free-Float |
99.73% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Celldex Therapeutics, Inc.
| 1 day | -1.52% | ||
| 1 week | +3.71% | ||
| Current month | +3.18% | ||
| 1 month | +4.95% | ||
| 3 months | +4.95% | ||
| 6 months | +26.68% | ||
| Current year | +19.40% |
| 1 week | 31.05 |  | 34.14 |
| 1 month | 28.38 | | 34.14 |
| Current year | 22.33 | | 35.79 |
| 1 year | 19.52 | | 35.79 |
| 3 years | 14.4 | | 53.18 |
| 5 years | 14.4 | | 57.2 |
| 10 years | 1.5 | | 75.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tibor Keler
CTO | Chief Tech/Sci/R&D Officer | 67 | 29/07/2014 |
Anthony Marucci
CEO | Chief Executive Officer | 64 | 31/08/2008 |
Sam Martin
DFI | Director of Finance/CFO | 55 | 31/03/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Anthony Marucci
BRD | Director/Board Member | 64 | 30/11/2008 |
Harry Penner
CHM | Chairman | 80 | 04/06/2025 |
Herbert Conrad
BRD | Director/Board Member | 93 | 29/02/2008 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01-01 | Fiscal year | Chief Financial Officer | 9,634 | 0.0145% | ||
| 12-14 | Fiscal year | Executive/Senior Manager | 38,666 | 0.0582% | ||
| 12-03 | Sell | General Counsel | 4,166 | 0.0063% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.52% | +3.71% | +58.20% | -11.92% | 2.55B | |
| +1.44% | +1.71% | -10.98% | -6.19% | 43.13B | |
| +3.31% | +5.93% | +310.97% | +534.70% | 34.65B | |
| +2.84% | +2.14% | +9.34% | +41.02% | 30.03B | |
| -1.70% | -7.54% | +8.43% | -21.94% | 28B | |
| -1.90% | -1.56% | +10.24% | +21.21% | 24.45B | |
| -0.14% | +5.86% | - | - | 14.34B | |
| +0.68% | -1.53% | +48.76% | +104.27% | 13.14B | |
| -0.57% | -2.43% | +5.08% | +4.79% | 12.53B | |
| -0.26% | +1.15% | +98.13% | +80.47% | 12.25B | |
| Average | +0.22% | +1.49% | +59.80% | +82.93% | 21.51B | |
| Weighted average by Cap. | +0.75% | +1.36% | +65.38% | +108.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.63M 2.3M 2.13M 2M 3.73M 248M 3.76M 25.23M 9.78M 122M 9.89M 9.68M 425M | 11.96M 10.44M 9.66M 9.06M 16.96M 1.13B 17.08M 115M 44.39M 555M 44.9M 43.93M 1.93B |
| Net income | -330M -288M -267M -250M -468M -31.13B -471M -3.16B -1.22B -15.32B -1.24B -1.21B -53.29B | -370M -323M -299M -281M -525M -34.94B -529M -3.55B -1.37B -17.2B -1.39B -1.36B -59.81B |
| Net Debt | -584M -510M -472M -442M -828M -55.09B -834M -5.59B -2.17B -27.11B -2.19B -2.15B -94.3B | -507M -443M -410M -384M -719M -47.85B -724M -4.86B -1.88B -23.55B -1.9B -1.86B -81.92B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/26 | 32.43 $ | -1.52% | 2,378,576 |
| 17/06/26 | 32.93 $ | +1.89% | 991,670 |
| 16/06/26 | 32.32 $ | +0.62% | 999,434 |
| 15/06/26 | 32.12 $ | +2.72% | 1,007,164 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CLDX Stock
Select your edition
All financial news and data tailored to specific country editions
